SLGL
SLGL
NASDAQ · Pharmaceuticals

Sol-Gel Technologies Ltd

$70.02
+0.48 (+0.69%)
As of May 8, 3:55 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target -82.3% upside
Low Target $7.31
Average Target $12.40
High Target $17.49
Current Price $70.02
Current
$70.02
Target
$12.40
$7.31 $12.40 avg $17.49
Scenario Analysis
Bear Case
$7.31
-89.6%
Low target
Base Case
$12.40
-82.3%
Avg target
Bull Case
$17.49
+-75.0%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$97.97
-28.5% from high
52-Week Low
$4.11
+1,603.6% from low
Target vs 52W High
$12.40
-87.3% vs high
Next Earnings Report
May 21, 2026
10d
until earnings
EPS Est: $-1.88
Earnings in 10 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%